Literature DB >> 22631043

Recent advances in the molecular understanding of non-transfusion-dependent thalassemia.

Renzo Galanello1.   

Abstract

Thalassemias are a group of inherited autosomal recessive hematologic disorders that occur because of defects in the alpha (α)- and beta (β)-globin genes of adult hemoglobin (Hb). An imbalance in the synthesis of one or more of the globin chains can result in a wide spectrum of phenotypes depending on the type and amount of globin synthesized and additional genetic modifiers. In patients with thalassemia intermedia, a condition known as non-transfusion-dependent thalassemia (NTDT), transfusion requirements are absent or episodic. Non-transfusion-dependent thalassemia includes β-thalassemia intermedia, HbE β-thalassemia, and α-thalassemia intermedia, also known as Hb H disease. This article focuses on the molecular features and genetic mutations specific to NTDT.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22631043     DOI: 10.1016/S0268-960X(12)70004-8

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  8 in total

1.  Thalassaemia intermedia: the role of erythroexchange in the treatment of an indolent wound.

Authors:  Marco Pignatti; Maurizio Govoni; Giuseppe Graldi; Lucrezia Pacchioni; Giorgio De Santis; Caterina Borgna
Journal:  Blood Transfus       Date:  2013-11-14       Impact factor: 3.443

Review 2.  Gene therapy for hemoglobinopathies: progress and challenges.

Authors:  Alisa Dong; Stefano Rivella; Laura Breda
Journal:  Transl Res       Date:  2013-01-19       Impact factor: 7.012

Review 3.  Deferasirox: a review of its use for chronic iron overload in patients with non-transfusion-dependent thalassaemia.

Authors:  Matt Shirley; Greg L Plosker
Journal:  Drugs       Date:  2014-06       Impact factor: 9.546

Review 4.  Non-transfusion-dependent thalassemias.

Authors:  Khaled M Musallam; Stefano Rivella; Elliott Vichinsky; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

5.  Altered erythropoiesis and iron metabolism in carriers of thalassemia.

Authors:  Jacqueline S Guimarães; Juçara G Cominal; Ana Cristina Silva-Pinto; Gordana Olbina; Yelena Z Ginzburg; Vijay Nandi; Mark Westerman; Stefano Rivella; Ana Maria de Souza
Journal:  Eur J Haematol       Date:  2014-11-11       Impact factor: 2.997

6.  Non-transfusion-dependent thalassemia: a complex mix of genetic entities yet to be fully discovered.

Authors:  Paolo Ricchi; Aldo Filosa; Aurelio Maggio; Suthat Fucharoen
Journal:  Biomed Res Int       Date:  2015-04-06       Impact factor: 3.411

Review 7.  Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes.

Authors:  Paolo Ricchi; Maria Marsella
Journal:  Drug Des Devel Ther       Date:  2015-12-16       Impact factor: 4.162

8.  Xmn1-158 γGVariant in B-Thalassemia Intermediate Patients in South-East of Iran.

Authors:  Ebrahim Miri-Moghaddam; Sara Bahrami; Majid Naderi; Ali Bazi; Morteza Karimipoor
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.